MedImmune, LLC
One MedImmune Way
Gaithersburg
Maryland
20878
United States
Tel: 301-398-0000
Fax: 301-398-9000
Website: http://www.medimmune.com/
About MedImmune, LLC
MedImmune is the worldwide biologics business for the AstraZeneca Group. The company has approximately 3,000 employees worldwide and is headquartered in Gaithersburg, Maryland with facilities in Pennsylvania, California, Kentucky, the United Kingdom, and the Netherlands. UK facilities include vaccine manufacturing operations in Speke and antibody discovery and research laboratories in Cambridge.
With two marketed products and an advancing pipeline of promising candidates in the areas of infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease and neuroscience, MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees.
352 articles with MedImmune, LLC
-
MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
11/14/2011
-
MedImmune Manufacturing Facility Recognized as 2011 Facility of the Year in Pharmaceutical Engineering
11/8/2011
-
MedImmune Named 2011 Facility of the Year Awards Overall Winner
11/7/2011
-
AgonOx Partners with MedImmune for Development of OX40 Agonists in Cancer Therapy
10/31/2011
-
MedImmune to Present Phase 3 Pediatric Clinical Data for Quadrivalent Influenza at 49th Annual IDSA Meeting
10/24/2011
-
MedImmune Release: "When Will You Pick?"(TM) Campaign Encourages Families to Make Flu Vaccination a Priority This Fall
10/13/2011
-
MedImmune In-Licenses Cancer Immunotherapy Tremelimumab from Pfizer Inc.
10/3/2011
-
MedImmune to Share Manufacturing Space With Merck & Co., Inc.
9/22/2011
-
Media Advisory 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 16-20
9/20/2011
-
MedImmune Sues Abbott Laboratories Over Drug Development Deal Gone Bad
8/24/2011
-
MedImmune Submits Supplemental Biologics License Application for Quadrivalent Seasonal Nasal Spray Influenza Vaccine
7/18/2011
-
MedImmune Release: FluMist® (Influenza Vaccine Live, Intranasal) Begins Shipping for 2011-2012 Influenza Season
7/18/2011
-
After Decades in the Industry, Ex MedImmune and Bristol-Myers Squibb Company Biotech Veteran Kiener Leads Gaithersburg's Zyngenia
7/15/2011
-
SAC Faces Insider Trading Probe on MedImmune
6/1/2011
-
MedImmune to Present Eight Abstracts on Projects Regarding Thoracic and Respiratory Issues at the Annual American Thoracic Society International Conference
5/13/2011
-
Pfenex Inc. Announces Strategic Collaboration With MedImmune for the Use of Pfenex Expression Technology(TM)
5/10/2011
-
MedImmune to Present Eleven Abstracts on Influenza and Respiratory Syncytial Virus at the Annual Pediatric Academic Societies Meeting
5/2/2011
-
MedImmune, INSERM and Inserm Transfert Announce Strategic Collaboration to Fund and Conduct Medical Science Research
4/4/2011
-
MedImmune to Present 11 Abstracts on Influenza at 45th Annual National Immunization Conference
3/29/2011
-
MedImmune and PDL BioPharma, Inc. Resolve Patent Disputes
2/16/2011